Real-World Evidence for Neonatal Drug Development: Challenges and Opportunities

被引：2
|
作者：
Singh, Kanwaljit [1 ]
Concato, John [2 ,3 ]
Davis, Jonathan M. [4 ,5 ]
机构：
[1] Crit Path Inst, Pediat Programs, Tucson, AZ USA
[2] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] Yale Univ, Dept Med, New Haven, CT USA
[4] Tufts Med Ctr, Dept Pediat, 800 Washington St, Boston, MA 02111 USA
[5] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
来源：
JOURNAL OF PEDIATRICS | 2024年 / 265卷
关键词：
D O I：
10.1016/j.jpeds.2023.113806
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Using Bayesian inverse modelling in real-world projects: opportunities and challenges
    Valstar, J. R.
    Minnema, B.
    Snepvangers, J. J. J. C.
    Stroet, C. B. M. Te
    CALIBRATION AND RELIABILITY IN GROUNDWATER MODELLING: FROM UNCERTAINTY TO DECISION MAKING, 2006, 304 : 108 - +
  • [42] REAL-WORLD DIETARY DATA COLLECTION: CURRENT CHALLENGES AND OPPORTUNITIES FOR INNOVATION
    Brett, N.
    Bassel, M.
    Hong, M.
    Margolis, M. K.
    VALUE IN HEALTH, 2022, 25 (01) : S221 - S221
  • [43] Rehabilitation Games in Real-World Clinical Settings: Practices, Challenges, and Opportunities
    Jung, Hee-Tae
    Park, Taiwoo
    MAhyar, Narges
    Park, Sungji
    Ryu, Taekyeong
    Kim, Yangsoo
    Lee, Sunghoon Ivan
    ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION, 2020, 27 (06)
  • [44] NGO perspectives on the challenges and opportunities for real-world evaluation: a qualitative study
    Sawadogo-Lewis, Talata
    Bryant, Ruth
    Roberton, Timothy
    GLOBAL HEALTH ACTION, 2022, 15 (01)
  • [45] The US Food and Drug Administration's Real-World Evidence Framework: A Commitment for Engagement and Transparency on Real-World Evidence
    ElZarrad, M. Khair
    Corrigan-Curay, Jacqueline
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 33 - 35
  • [46] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [47] Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group
    Morland, Kellie
    Gerges, Christian
    Elwing, Jean
    Visovatti, Scott H.
    Weatherald, Jason
    Gillmeyer, Kari R.
    Sahay, Sandeep
    Mathai, Stephen C.
    Boucly, Athenais
    Williams, Paul G.
    Harikrishnan, Sivadasanpillai
    Minty, Evan P.
    Hobohm, Lukas
    Jose, Arun
    Badagliacca, Roberto
    Lau, Edmund M. T.
    Jing, Zhi-Cheng
    Vanderpool, Rebecca R.
    Fauvel, Charles
    Leonidas Alves, Jose, Jr.
    Strange, Geoff
    Pulido, Tomas
    Qian, Junyan
    Li, Mengtao
    Mercurio, Valentina
    Zelt, Jason G. E.
    Moles, Victor M.
    Cirulis, Meghan M.
    Nikkho, Sylvia M.
    Benza, Raymond L.
    Elliott, C. Gregory
    PULMONARY CIRCULATION, 2023, 13 (04)
  • [48] The use of real-world data in cancer drug development
    Skovlund, E.
    Leufkens, H. G. M.
    Smyth, J. F.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 69 - 76
  • [49] USING REAL-WORLD EVIDENCE TO SUPPORT REIMBURSEMENT DECISION-MAKING IN CHINA: CURRENT PRACTICES, CHALLENGES AND OPPORTUNITIES
    Liu, J.
    Feng, Y.
    Yang, S.
    Yin, Z.
    Xie, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S141 - S141
  • [50] Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors
    Fadini, Gian Paolo
    Del Prato, Stefano
    Avogaro, Angelo
    Solini, Anna
    DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 177 - 186
12345